AnalystsLuca IssiLuca Issi's Stock Forecasts
AnalystsLuca Issi
Sectors:
Industries:
Analyst Ranking
Bottom 3%
#4766 out of 4862 analysts
Average Return
-20.18%
Win Rate
21%26 out of 124
Risk vs Reward
Poor
Good
Luca Issi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Uniqure NvQURE | +137.93% | $5.88 | $13.99 | 2024-01-16 - 2025-01-15 | Buy |
Uniqure NvQURE | +85.61% | $7.16 | $13.29 | 2024-11-06 - 2025-04-21 | Buy |
Alnylam Pharmaceuticals IncALNY | +74.46% | $147.00 | $256.45 | 2024-02-16 - 2025-02-14 | Buy |
Alnylam Pharmaceuticals IncALNY | +67.35% | $149.69 | $250.51 | 2024-02-20 - 2025-02-19 | Buy |
Alnylam Pharmaceuticals IncALNY | +66.02% | $167.82 | $278.62 | 2023-10-11 - 2024-10-10 | Buy |
Luca Issi Analyst Color
Get additional color on Luca Issi's coverage of popular stocks
Luca Issi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Apellis Pharmaceuticals IncAPLS | 6 | Hold | $21.00 | +16.47% | Maintains | a day ago |
Adverum Biotechnologies IncADVM | 7 | Hold | $5.00 | +83.15% | Maintains | 6 days ago |
Ascendis Pharma AASND | 1 | Buy | $205.00 | +27.21% | Initiates Coverage On | 6 days ago |
Lexeo Therapeutics IncLXEO | 5 | Buy | $20.00 | +523.05% | Maintains | a month ago |
Alnylam Pharmaceuticals IncALNY | 26 | Buy | $330.00 | +41.78% | Maintains | a month ago |
Korro Bio IncKRRO | 7 | Buy | $95.00 | +596.48% | Maintains | a month ago |
Sangamo Therapeutics IncSGMO | 6 | Hold | $2.00 | +171.74% | Reiterates | a month ago |
Ocular Therapeutix IncOCUL | 1 | Buy | $17.00 | +123.39% | Initiates Coverage On | a month ago |
Meiragtx Holdings PLCMGTX | 6 | Buy | $13.00 | +130.09% | Maintains | a month ago |
Allogene Therapeutics IncALLO | 7 | Buy | $10.00 | +604.23% | Reiterates | a month ago |
Verve Therapeutics IncVERV | 7 | Buy | $15.00 | +213.81% | Maintains | 2 months ago |
4d Molecular Therapeutics IncFDMT | 7 | Buy | $35.00 | +1,036.36% | Maintains | 2 months ago |
Beam Therapeutics IncBEAM | 7 | Hold | $26.00 | +42.54% | Maintains | 2 months ago |
Ionis Pharmaceuticals IncIONS | 8 | Buy | $70.00 | +145.53% | Reiterates | 2 months ago |
Biomarin Pharmaceutical IncBMRN | 12 | Hold | $70.00 | +19.35% | Reiterates | 2 months ago |
Moderna IncMRNA | 13 | Hold | $40.00 | +59.17% | Reiterates | 2 months ago |
Crispr Therapeutics AgCRSP | 12 | Hold | $48.00 | +26.92% | Maintains | 2 months ago |
Arrowhead Pharmaceuticals IncARWR | 8 | Buy | $42.00 | +247.68% | Reiterates | 2 months ago |
Uniqure NvQURE | 6 | Buy | $24.00 | +80.59% | Reiterates | 3 months ago |
Schlumberger LimitedSLB | 1 | Buy | $57.00 | +64.64% | Reiterates | 3 months ago |
Regenxbio IncRGNX | 8 | Buy | $30.00 | +349.78% | Reiterates | 3 months ago |
Avidity Biosciences IncRNA | 2 | Buy | $67.00 | +134.92% | Reiterates | 3 months ago |
Dyne Therapeutics IncDYN | 2 | Buy | $45.00 | +382.32% | Reiterates | 3 months ago |
Editas Medicine IncEDIT | 8 | Hold | $4.00 | +200.75% | Maintains | 4 months ago |
Bluebird Bio IncBLUE | 4 | Hold | $80.00 | +1,951.28% | Reiterates | 5 months ago |
Ultragenyx Pharmaceutical IncRARE | 3 | Buy | $77.00 | +117.51% | Reiterates | 6 months ago |
Wave Life Sciences LtdWVE | 5 | Hold | $15.00 | +145.10% | Maintains | 6 months ago |
Intellia Therapeutics IncNTLA | 4 | Buy | $54.00 | +581.82% | Reiterates | 7 months ago |
Caribou Biosciences IncCRBU | 5 | Buy | $14.00 | +1,661.01% | Reiterates | 8 months ago |
Lenz Therapeutics IncLENZ | 3 | Hold | $3.00 | N/A | Maintains | 2 years ago |
Q32 Bio IncQTTB | 3 | Hold | $54.00 | N/A | Maintains | 2 years ago |
Dicerna Pharmaceuticals IncDRNA | 2 | Hold | $38.25 | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.